Georgia Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 31 (89% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 11,374
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 58.44%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,491
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 50.93%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 39.93% 48.02%
White, Hispanic/Latino Patients 6.10% 6.91%
Black/African American, Non-Hispanic/Latino Patients 45.01% 38.36%
Black/African American, Hispanic/Latino Patients 0.58% 0.20%
Asian Patients3 0.68% 0.80%
American Indian/Alaska Native Patients3 0.21% 0.54%
Native Hawaiian/Other Pacific Islander Patients3 0.17% 0.13%
Patients with More than one race3 1.43% 1.68%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.98% 1.21%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.32% 1.27%
Unreported/Refused to Report Race and Ethnicity 1.59% 0.87%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,775
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 79.17%
COVID-19 Immunization Series Completed 2,079
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 74.25%
COVID-19 Immunization Series Additional 433
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 60.45%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 20.11% 24.72% 36.26%
White, Hispanic/Latino Patients 14.03% 16.45% 4.16%
Black/African American, Non-Hispanic/Latino Patients 57.63% 49.69% 45.50%
Black/African American, Hispanic/Latino Patients 0.73% 0.58% 2.08%
Asian Patients3 0.28% 0.58% 1.85%
American Indian/Alaska Native Patients3 0.28% 0.29% 1.39%
Native Hawaiian/Other Pacific Islander Patients3 0.39% 0.48% 0.00%
Patients with More than one race3 0.79% 0.67% 0.46%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.31% 2.55% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.80% 1.73% 8.31%
Unreported/Refused to Report Race and Ethnicity 1.63% 2.26% 0.00%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 16.13%
1 to 24 Hours 25.81%
More Than 24 Hours 58.06%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 16.13%
Vaccine confidence 45.16%
Vaccine storage capacity 0.00%
Vaccine supply 3.23%
Other 9.68%
None 29.03%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 89.68%
Average Percent of Health Center Visits Conducted Virtually 8.39%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 45.16%
Number of Mobile Van Sites 26
Number of Pop-up Clinics 21
Number of School-Based Vaccination Sites 3

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 6.45%
Refer patients to another organization that provides monoclonal antibody therapies 45.16%
None 48.39%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 9.68%
Patient awareness/education 3.23%
Staffing capacity 16.13%
Therapy administration/onsite logistics 9.68%
Other 16.13%
None 51.61%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021